Bioengineered Proteins Drugs Market by Application, Types, End-User, Regional Analysis and Forecast to 2015 – 2023
Bio engineered proteins drugs are synthesized through genetic engineering for treatment of human injury, systemic treatments of cancers, organ transplants etc. They are also known as Recombinant Protein drugs and are used for modification of immune reactions, through patho physiological pathways at multiple levels of cells adhesion and activation. The bio engineered protein drugs are created through the recombinant DNA technology. The market for bio engineered protein drugs has been segmented by type of drug into cytokines and chemokine's, monoclonal...
View full press release